![](/images/general/no_picture/200_user.png)
Paul F Urrutia
Examiner (ID: 8172)
Art Unit(s) | OPLC |
Total Applications | 5 |
Issued Applications | 0 |
Pending Applications | 5 |
Abandoned Applications | 0 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 16703190
[patent_doc_number] => 10953104
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-23
[patent_title] => Dimeric collagen hybridizing peptides and methods of using
[patent_app_type] => utility
[patent_app_number] => 15/547504
[patent_app_country] => US
[patent_app_date] => 2016-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 20
[patent_no_of_words] => 15144
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15547504
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/547504 | Dimeric collagen hybridizing peptides and methods of using | Jan 28, 2016 | Issued |
Array
(
[id] => 10791570
[patent_doc_number] => 20160137726
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-19
[patent_title] => 'SINGLE DOMAIN BINDING MOLECULE'
[patent_app_type] => utility
[patent_app_number] => 15/005463
[patent_app_country] => US
[patent_app_date] => 2016-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 13236
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15005463
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/005463 | Single domain binding molecule | Jan 24, 2016 | Issued |
Array
(
[id] => 11011029
[patent_doc_number] => 20160207979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-21
[patent_title] => 'MULTIVALENT HETEROMULTIMER SCAFFOLD DESIGN AND CONSTRUCTS'
[patent_app_type] => utility
[patent_app_number] => 15/001078
[patent_app_country] => US
[patent_app_date] => 2016-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 52
[patent_figures_cnt] => 52
[patent_no_of_words] => 57730
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15001078
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/001078 | Multivalent heteromultimer scaffold design and constructs | Jan 18, 2016 | Issued |
Array
(
[id] => 13425193
[patent_doc_number] => 20180264139
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-20
[patent_title] => COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 15/537577
[patent_app_country] => US
[patent_app_date] => 2015-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18869
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15537577
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/537577 | Thyroid stimulating hormone receptor peptides and uses thereof | Dec 22, 2015 | Issued |
Array
(
[id] => 12584907
[patent_doc_number] => 20180086798
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-29
[patent_title] => NOVEL PI3K GAMMA INHIBITOR PEPTIDE FOR TREATMENT OF RESPIRATORY SYSTEM DISEASES
[patent_app_type] => utility
[patent_app_number] => 15/539339
[patent_app_country] => US
[patent_app_date] => 2015-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8700
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15539339
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/539339 | PI3K gamma inhibitor peptide for treatment of respiratory system diseases | Dec 21, 2015 | Issued |
Array
(
[id] => 14975503
[patent_doc_number] => 10441638
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-15
[patent_title] => Cyclic acetylcholinesterase c-terminal peptide in the treatment or prevention of cancer or metastasis
[patent_app_type] => utility
[patent_app_number] => 15/535020
[patent_app_country] => US
[patent_app_date] => 2015-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 26
[patent_no_of_words] => 7901
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15535020
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/535020 | Cyclic acetylcholinesterase c-terminal peptide in the treatment or prevention of cancer or metastasis | Dec 17, 2015 | Issued |
Array
(
[id] => 13867569
[patent_doc_number] => 20190030125
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-31
[patent_title] => USE OF FIBULIN-5 FOR THE TREATMENT OF KELOID SCARS
[patent_app_type] => utility
[patent_app_number] => 15/533691
[patent_app_country] => US
[patent_app_date] => 2015-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9467
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15533691
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/533691 | USE OF FIBULIN-5 FOR THE TREATMENT OF KELOID SCARS | Dec 6, 2015 | Abandoned |
Array
(
[id] => 14422541
[patent_doc_number] => 10316060
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-11
[patent_title] => Energy transfer within pi-conjugated peptide heterostructures in aqueous environments
[patent_app_type] => utility
[patent_app_number] => 14/950603
[patent_app_country] => US
[patent_app_date] => 2015-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 52
[patent_figures_cnt] => 172
[patent_no_of_words] => 30552
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 216
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14950603
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/950603 | Energy transfer within pi-conjugated peptide heterostructures in aqueous environments | Nov 23, 2015 | Issued |
Array
(
[id] => 11895194
[patent_doc_number] => 09765119
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-09-19
[patent_title] => 'Cyclosporine analogue mixtures and their use as immunomodulating agents'
[patent_app_type] => utility
[patent_app_number] => 14/949616
[patent_app_country] => US
[patent_app_date] => 2015-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 18
[patent_no_of_words] => 25257
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14949616
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/949616 | Cyclosporine analogue mixtures and their use as immunomodulating agents | Nov 22, 2015 | Issued |
Array
(
[id] => 13867547
[patent_doc_number] => 20190030114
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-31
[patent_title] => ISOFORM-SPECIFIC CALPAIN INHIBITORS, METHODS OF IDENTIFICATION, AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/525849
[patent_app_country] => US
[patent_app_date] => 2015-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21575
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15525849
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/525849 | ISOFORM-SPECIFIC CALPAIN INHIBITORS, METHODS OF IDENTIFICATION, AND USES THEREOF | Nov 10, 2015 | Abandoned |
Array
(
[id] => 10769056
[patent_doc_number] => 20160115212
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-28
[patent_title] => 'TUMOR-ASSOCIATED PEPTIDES BINDING PROMISCUOUSLY TO HUMAN LEUKOCYTE ANTIGEN (HLA) CLASS II MOLECULES'
[patent_app_type] => utility
[patent_app_number] => 14/933077
[patent_app_country] => US
[patent_app_date] => 2015-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 23326
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14933077
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/933077 | Tumor-associated peptides binding promiscuously to human leukocyte antigen (HLA) class II molecules | Nov 4, 2015 | Issued |
Array
(
[id] => 10774779
[patent_doc_number] => 20160120936
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-05
[patent_title] => 'METHODS OF PREVENTING SURGICAL SITE INFECTIONS'
[patent_app_type] => utility
[patent_app_number] => 14/928281
[patent_app_country] => US
[patent_app_date] => 2015-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6706
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14928281
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/928281 | METHODS OF PREVENTING SURGICAL SITE INFECTIONS | Oct 29, 2015 | Abandoned |
Array
(
[id] => 12051212
[patent_doc_number] => 20170327557
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-16
[patent_title] => 'Efficient delivery of therapeutic molecules to cells of the inner ear'
[patent_app_type] => utility
[patent_app_number] => 15/523317
[patent_app_country] => US
[patent_app_date] => 2015-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 33465
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 40
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15523317
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/523317 | Efficient delivery of therapeutic molecules to cells of the inner ear | Oct 28, 2015 | Issued |
Array
(
[id] => 14977867
[patent_doc_number] => 10442834
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-15
[patent_title] => Deprotection method
[patent_app_type] => utility
[patent_app_number] => 14/873517
[patent_app_country] => US
[patent_app_date] => 2015-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5983
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 216
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14873517
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/873517 | Deprotection method | Oct 1, 2015 | Issued |
Array
(
[id] => 16490531
[patent_doc_number] => 10856546
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-08
[patent_title] => Hypersensitive response elicitor peptides and use thereof
[patent_app_type] => utility
[patent_app_number] => 14/872298
[patent_app_country] => US
[patent_app_date] => 2015-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 26
[patent_no_of_words] => 32548
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14872298
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/872298 | Hypersensitive response elicitor peptides and use thereof | Sep 30, 2015 | Issued |
Array
(
[id] => 16244220
[patent_doc_number] => 10743538
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-18
[patent_title] => Elicitor peptides having disrupted hypersensitive response box and use thereof
[patent_app_type] => utility
[patent_app_number] => 14/872347
[patent_app_country] => US
[patent_app_date] => 2015-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28290
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14872347
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/872347 | Elicitor peptides having disrupted hypersensitive response box and use thereof | Sep 30, 2015 | Issued |
Array
(
[id] => 16490531
[patent_doc_number] => 10856546
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-08
[patent_title] => Hypersensitive response elicitor peptides and use thereof
[patent_app_type] => utility
[patent_app_number] => 14/872298
[patent_app_country] => US
[patent_app_date] => 2015-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 26
[patent_no_of_words] => 32548
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14872298
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/872298 | Hypersensitive response elicitor peptides and use thereof | Sep 30, 2015 | Issued |
Array
(
[id] => 11993945
[patent_doc_number] => 20170298100
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-19
[patent_title] => 'ANTI-VIRAL PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 15/515971
[patent_app_country] => US
[patent_app_date] => 2015-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 15920
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15515971
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/515971 | ANTI-VIRAL PEPTIDES | Sep 29, 2015 | Abandoned |
Array
(
[id] => 10729614
[patent_doc_number] => 20160075763
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-17
[patent_title] => 'ALBUMIN VARIANTS'
[patent_app_type] => utility
[patent_app_number] => 14/863868
[patent_app_country] => US
[patent_app_date] => 2015-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 28930
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14863868
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/863868 | ALBUMIN VARIANTS | Sep 23, 2015 | Abandoned |
Array
(
[id] => 10663642
[patent_doc_number] => 20160009787
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-14
[patent_title] => 'ALBUMIN VARIANTS'
[patent_app_type] => utility
[patent_app_number] => 14/863628
[patent_app_country] => US
[patent_app_date] => 2015-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 29003
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14863628
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/863628 | ALBUMIN VARIANTS | Sep 23, 2015 | Abandoned |